Shivom Revenue and Competitors
Estimated Revenue & Valuation
- Shivom's estimated annual revenue is currently $3.4M per year.
- Shivom's estimated revenue per employee is $155,000
Employee Data
- Shivom has 22 Employees.
- Shivom grew their employee count by 5% last year.
Shivom's People
| Name | Title | Email/Phone |
|---|
Shivom Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 35 | -12% | N/A | N/A |
#2 | $16.3M | 105 | 4% | N/A | N/A |
#3 | $2.6M | 830 | 30% | $631.7M | N/A |
#4 | $18.1M | 117 | -8% | $81M | N/A |
#5 | $1.2M | 271 | 12% | $440M | N/A |
#6 | $54.6M | 282 | 0% | $132.9M | N/A |
#7 | $9.3M | 60 | -37% | N/A | N/A |
#8 | $21.2M | 137 | 12% | N/A | N/A |
#9 | $408.2M | 1646 | 11% | £994.6M | N/A |
#10 | $963.5M | 6216 | 12% | N/A | N/A |
What Is Shivom?
We are a London-based healthcare data analytics & AI company, building the world's largest genetic & precision medicine data marketplace. Our blockchain and AI-based platform solves several problems the global research community faces (e.g. siloed data, cross-border data sharing, lack of state-of-the-art analytic tools, GDPR-compliance) by providing a next-generation data sharing- & data analytics ecosystem, lifting precision medicine, drug discovery, and translational research into a new era of democratized healthcare. We provide an epidemic preparedness platform; a trusted global data exchange & AI analytics eco-system designed to advance research on, and health responses to, the COVID-19 pandemic and future outbreaks.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Shivom News
Parikant Shivom Shandil.(Middle) with parents Kusum and Harish at their home in Rara Housing Lajonnia Labasa, Photo: Sampras Anand...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 22 | -8% | $10M |
#2 | $2M | 22 | N/A | $8M |
#3 | $3.2M | 22 | -15% | N/A |
#4 | $2.2M | 22 | -15% | N/A |
#5 | $3.2M | 22 | 22% | N/A |